View in EDS HTML Full Text PDF Full Text

Cost-Effectiveness of Adjuvanted Quadrivalent Influenza Vaccine for Adults over 65 in France.

Saved in:
Bibliographic Details
Title: Cost-Effectiveness of Adjuvanted Quadrivalent Influenza Vaccine for Adults over 65 in France.
Authors: Paccalin M; Geriatrics Department CHU Poitiers, 86000 Poitiers, France., Gavazzi G; CHU Grenoble, 38000 Grenoble, France., Berkovitch Q; Public Health Expertise, 75004 Paris, France., Leleu H; Public Health Expertise, 75004 Paris, France., Moreau R; Public Health Expertise, 75004 Paris, France., Ciglia E; Seqirus GmbH, Medical Affairs, 81929 Munich, Germany., Burlet N; Vifor Pharma, 92042 Paris, France., Mould-Quevedo JF; Seqirus USA Inc., Medical Affairs, Summit, NJ 07901, USA.
Source: Vaccines [Vaccines (Basel)] 2024 May 24; Vol. 12 (6). Date of Electronic Publication: 2024 May 24.
Publication Type: Journal Article
Journal Info: Publisher: MDPI AG Country of Publication: Switzerland NLM ID: 101629355 Publication Model: Electronic Cited Medium: Print ISSN: 2076-393X (Print) Linking ISSN: 2076393X NLM ISO Abbreviation: Vaccines (Basel) Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:2076-393X
DOI:10.3390/vaccines12060574